scholarly journals The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990–2019: a population-based study

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Yi Feng Wen ◽  
Meng Xuan Chen ◽  
Guosheng Yin ◽  
Ruitao Lin ◽  
Yu Jie Zhong ◽  
...  
Keyword(s):  
Young Adults ◽  
Incidence Rate ◽  
Older Adult ◽  
Western Europe ◽  
Limited Resource ◽  
Population Based ◽  
Adolescents And Young Adults ◽  
Global Burden ◽  
Life Years ◽  
Incident Cases

Abstract Background Accurate appraisal of burden of adolescents and young adults (AYAs) cancers is crucial to informing resource allocation and policy making. We report on the latest estimates of burden of AYA cancers in 204 countries and territories between 1990 and 2019 in association with socio-demographic index (SDI). Patients and methods Estimates from the Global Burden of Disease study 2019 were used to analyse incidence, mortality, and disability-adjusted life years (DALYs) due to AYA cancers at global, regional, and national levels by sex. Association between AYA cancer burden and SDI were investigated. Burdens of AYA cancers were contextualized in comparison with childhood and older adult cancers. All estimates are reported as counts and age-standardized rates per 100,000 person-years. Results In 2019, there were 1.2 million incident cases, 0.4 million deaths, and 23.5 million DALYs due to AYA cancers globally. The highest age-standardized incidence rate occurred in Western Europe (75.3 [Females] and 67.4 [Males] per 100,000 person-years). Age-standardized death (23.2 [Females] and 13.9 [Males] per 100,000 person-years) and DALY (1328.3 [Females] and 1059.2 [Males] per 100,000 person-years) rates were highest in Oceania. Increasing SDI was associated with a higher age-standardized incidence rate. An inverted U-shaped association was identified between SDI and death and DALY rates. AYA cancers collectively is the second leading cause of non-communicable diseases-related deaths globally in 2019. DALYs of AYA cancers ranked the second globally and the first in low and low-middle SDI locations when compared with that of childhood and older adult cancers. Conclusion The global burden of AYA cancers is substantial and disproportionally affect populations in limited-resource settings. Capacity building for AYA cancers is essential in promoting equity and population health worldwide.

scholarly journals Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Linghui Zhou ◽  
Qin Yu ◽  
Guoqing Wei ◽  
Linqin Wang ◽  
Yue Huang ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
United Arab Emirates ◽  
Western Europe ◽  
Population Aging ◽  
Health Concern ◽  
Global Burden ◽  
Life Years ◽  
National Burden ◽  
Disease Study ◽  
Incident Cases

Abstract Background Multiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific local strategies. Therefore, we evaluated the epidemiologic patterns and explored the risk factors for MM death. Methods Data on MM were collected from the 2019 Global Burden of Disease study. We used incidence, mortality, and disability adjusted life-years to estimate the global, regional, and national burden of MM. Results In 2019, there were 155,688 (95% UI, 136,585 – 172,577) MM cases worldwide, of which 84,516 (54.3%, 70,924 – 94,910) were of men. The age-standardized incidence rate (ASIR) was 1.72/100,000 persons (95% UI, 1.59–1.93) in 1990 and 1.92/100,000 persons (95% UI, 1.68–2.12) in 2019. The number of MM deaths increased 1.19-fold from 51,862 (95% UI, 47,710–58,979) in 1990 to 113,474 (95% UI, 99,527 – 121,735) in 2019; the age-standardized death rate (ASDR) was 1.42/100,000 persons (95% UI, 1.24–1.52) in 2019. In recent 15 years, ASDR showed a steady tendency for men, and a downward tendency for women. Countries with high social-demographic indexes exhibited a higher ASIR and ASDR. Australasia, North America, and Western Europe had the highest ASIR and ASDR, with 46.3% incident cases and 41.8% death cases. Monaco had the highest ASIR and ASDR, which was almost half as high as the second highest country Barbados. In addition, United Arab Emirates and Qatar had the largest growth multiple in ASIR and ASDR, which was twice the third country Djibouti. Conclusions Globally, incident and death MM cases have more than doubled over the past 30 years. The increasing global burden may continue with population aging, whereas mortality may continue to decrease with the progression of medical technology. The global burden pattern of MM was diverse, therefore specific local strategies based on different burden patterns for MM are necessary.

Global Burden of Sexually Transmitted Infections: 1990 - 2019

2021 ◽  
Author(s):  
Jiaofeng Huang ◽  
Su Lin ◽  
Jinshui Pan ◽  
Lingling Lu ◽  
Bang Liu ◽  
...  
Keyword(s):  
Sexually Transmitted Infections ◽  
Incidence Rate ◽  
Disease Burden ◽  
Global Burden ◽  
Sexually Transmitted ◽  
Disability Adjusted Life ◽  
Younger Age ◽  
Life Years ◽  
Disease Study ◽  
Incident Cases

Abstract BackgroundSexually transmitted infections (STIs) are major public health problems worldwide. Understanding the disease burden are crucial for health policy making. This study was to assess global and regional STIs incidence, mortality and disability‐adjusted life years (DALYs) from 1990 to 2019.Methods­­­­Data were extracted from the Global Burden of Disease study 2019, which is an open database for download. Age-standardized rate and estimated annual percentage changes (EAPC) were calculated to evaluate the burden of STIs over time.ResultsIn 2019, the total number of incident cases of STIs was 769.85 million worldwide. The age-standardized incidence rate was stable from 1990 to 2019 with the EAPC of −0.04 (95% UI: −0.09 to 0.01). In 2019, the number of deaths caused by STIs was 89.89×103, which was 15.51% lower than that of 1990 (106.52×103). A decreasing trend from 1990 to 2019 was observed in the age-standardized death and DALYs. The age-standardized death and DALYs rate due to STIs were the highest in the younger age (<14 years old). As for different diseases, syphilis was the least common STIs with an age-standardized incidence rate of 178.48/100,000, while syphilis was also the main contributor to the age-standardized death and DALYs rate. These two indicators were negatively associated with sociodemographic level.ConclusionsThe global incidence of STIs has been persistently high from 1990 to 2019, while the age-standardized death and DALYs rate has decreased recently. More attention should be paid to the younger population, patients with syphilis and regions with low sociodemographic index.

scholarly journals Risk of suicide attempts in adolescents and young adults with attention-deficit hyperactivity disorder: a nationwide longitudinal study

2018 ◽  
Vol 212 (4) ◽  
pp. 234-238 ◽  
Author(s):  
Kai-Lin Huang ◽  
Han-Ting Wei ◽  
Ju-Wei Hsu ◽  
Ya-Mei Bai ◽  
Tung-Ping Su ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Young Adults ◽  
Risk Factor ◽  
Suicide Attempt ◽  
Attention Deficit ◽  
Suicide Attempts ◽  
Population Based ◽  
Hazard Ratio ◽  
Adolescents And Young Adults ◽  
Hyperactivity Disorder

BackgroundAttention-deficit hyperactivity disorder (ADHD) increases the risk of suicidal behaviours through psychiatric comorbidities; however, a significant direct association has not been observed between ADHD and suicide attempts.AimsTo evaluate the risk of suicide attempt in adolescents and young adults with ADHD.MethodUsing a nationwide, population-based insurance claims database, this longitudinal cohort study enrolled 20 574 adolescents and young adults with ADHD and 61 722 age- and gender-matched controls between 2001 and 2009. Any suicide attempt was identified from enrolment to 31 December 2011. The association between ADHD medications and the likelihood of suicide attempt was assessed.ResultsADHD was an independent risk factor for any suicide attempt (hazard ratio = 3.84, 95% CI = 3.19–4.62) and repeated suicide attempts (hazard ratio = 6.52, 95% CI = 4.46–9.53). Subgroup analyses of men, women, adolescents and young adults demonstrated the same trend. Methylphenidate or atomoxetine treatment did not increase the risk of suicide attempt or repeated suicide attempts. Long-term methylphenidate treatment was associated with a significantly decreased risk of repeated suicide attempts in men (hazard ratio = 0.46, 95% CI = 0.22–0.97).ConclusionADHD was a risk factor for suicide attempt and a stronger predictor of repeated suicide attempts, independent of comorbidities. Further investigation is warranted to explore the mechanism underlying the association between ADHD and suicidal behaviours.Declaration of interestNone.

scholarly journals The trends in global, regional, and national incidence of pneumoconiosis caused by different etiologies: an analysis from the Global Burden of Disease Study 2017

2019 ◽  
Author(s):  
Peng Shi ◽  
Xiaoyue Xing ◽  
Shuhua Xi ◽  
Hongmei Jing ◽  
Jiamei Yuan ◽  
...  
Keyword(s):  
Incidence Rate ◽  
Burden Of Disease ◽  
Incidence Rates ◽  
Global Burden Of Disease ◽  
Health Concern ◽  
Global Burden ◽  
Incidence Trends ◽  
The World ◽  
Disease Study ◽  
Incident Cases

Abstract Pneumoconiosis has the potential to cause progressive and permanent physical disability. And continues to be one of major public health concern across the world. However, our literature searches identified a scarcity of data about global prevalence of pneumoconiosis. Accurate data on the incidence of pneumoconiosis is critical for health resource planning and health policy development. We therefore aimed to determine the pattern of pneumoconiosis incidence and temporal trends. Methods: Annual incident cases and age standardized incidence rates on pneumoconiosis etiology between 1990-2017 were collected from the Global Burden of Disease Study 2017. We calculate the average annual percentage changes of age standardized incidence rates by sex, region, and etiology to determine incidence trends of pneumoconiosis. Results: Globally, the number of pneumoconiosis cases increased 66.0% from 36,186 in 1990 to 60,055 in 2017. The overall age standardized incidence rate decreased by an average 0.6% (95% CI: 0.5%, 0.6%) per year in the same period. The age standardized incidence rate of silicosis, asbestosis, and other pneumoconiosis decreased between 1990 and 2017. The corresponding average annual percentage changes were -0.8%, -0.9%, and -0.5%, respectively. The age standardized incidence rate of asbestosis displayed an increasing trend. At the same time, we also found a significant negative association was found between average annual percentage changes and socio-demographic indexs when the socio-demographic index above 0.7. Conclusions: Pneumoconiosis remains a major occupational health illnesses in the world. Incidence patterns of pneumoconiosis caused by different etiologies were heterogeneous across regions and countries. We observed an unfavorable trend that asbestosis was predominant in countries with a high socio-demographic index, though we have attained great achievements in silicosis and coal workers’ pneumoconiosis prevention. The information in this study suggests that some countries should establish more targeted and specific strategies to forestall the increase in pneumoconiosis.

scholarly journals Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study

2016 ◽  
Vol 173 (2) ◽  
pp. 292-302 ◽  
Author(s):  
Renata Abrahão ◽  
Ruth H. Keogh ◽  
Daphne Y. Lichtensztajn ◽  
Rafael Marcos-Gragera ◽  
Bruno C. Medeiros ◽  
...  
Keyword(s):  
Young Adults ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Early Death ◽  
Population Based ◽  
Adolescents And Young Adults ◽  
Population Based Study ◽  
Acute Myeloid

scholarly journals Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017

2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Na Li ◽  
Yujiao Deng ◽  
Linghui Zhou ◽  
Tian Tian ◽  
Si Yang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Burden Of Disease ◽  
Attributable Risk ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Cancer Burden ◽  
Cancer Data ◽  
Life Years ◽  
Incident Cases

Abstract Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.

Sign in / Sign up

Export Citation Format

Share Document